APO Research

APO RESEARCH · REPORT

Poultry Vaccines

Selected research

Market Analysis & Forecast

Global Poultry Vaccines Market Analysis and Forecast 2026-2032

Market perspective

The global Poultry Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Poultry Vaccines include Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike and Phibro Animal Health Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Poultry Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Poultry Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Poultry Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Poultry Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Poultry Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Poultry Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Poultry Vaccines Segment by Company

Merck

Boehringer Ingelheim

Ceva

Zoetis

Vaxxinova®

Elanco

QYH Biotech Co., Ltd

Pulike

Phibro Animal Health Corporation

JinYu Biotechnology

Harbin Pharmaceutical Group

MEVAC

Venky's

Japfa Comfeed Indonesia

Nisseiken

Hile

Hester Biosciences

Poultry Vaccines Segment by Type

Live

Attenuated

Killed

Poultry Vaccines Segment by Application

NDV

Marek ' s Disease

IBD

Infectious Bronchitis

Influenza

Others

Poultry Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poultry Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poultry Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poultry Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Poultry Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Poultry Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poultry Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Poultry Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Major Player Table 3. Attenuated Major Player Table 4. Killed Major Player Table 5. Global Poultry Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. NDV Major Player Table 7. Marek ' s Disease Major Player Table 8. IBD Major Player Table 9. Infectious Bronchitis Major Player Table 10. Influenza Major Player Table 11. Others Major Player Table 12. Poultry Vaccines Industry Trends Table 13. Poultry Vaccines Industry Drivers Table 14. Poultry Vaccines Industry Opportunities and Challenges Table 15. Poultry Vaccines Industry Restraints Table 16. Global Poultry Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Poultry Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Poultry Vaccines Market Share by Region (2021-2026) Table 19. Global Poultry Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Poultry Vaccines Market Share by Region (2027-2032) Table 21. Global Poultry Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Poultry Vaccines Revenue Market Share by Players (2021-2026) Table 23. Global Poultry Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Poultry Vaccines Key Players Headquarters & Area Served Table 25. Global Poultry Vaccines Players, Product Type & Application Table 26. Global Poultry Vaccines Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Poultry Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Poultry Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Poultry Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Poultry Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Poultry Vaccines Revenue Market Share by Type (2021-2026) Table 33. Global Poultry Vaccines Revenue Market Share by Type (2027-2032) Table 34. Global Poultry Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Poultry Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Poultry Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Poultry Vaccines Revenue Market Share by Application (2021-2026) Table 38. Global Poultry Vaccines Revenue Market Share by Application (2027-2032) Table 39. Merck Company Information Table 40. Merck Business Overview Table 41. Merck Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Merck Poultry Vaccines Product Portfolio Table 43. Merck Recent Development Table 44. Boehringer Ingelheim Company Information Table 45. Boehringer Ingelheim Business Overview Table 46. Boehringer Ingelheim Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Boehringer Ingelheim Poultry Vaccines Product Portfolio Table 48. Boehringer Ingelheim Recent Development Table 49. Ceva Company Information Table 50. Ceva Business Overview Table 51. Ceva Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Ceva Poultry Vaccines Product Portfolio Table 53. Ceva Recent Development Table 54. Zoetis Company Information Table 55. Zoetis Business Overview Table 56. Zoetis Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Zoetis Poultry Vaccines Product Portfolio Table 58. Zoetis Recent Development Table 59. Vaxxinova® Company Information Table 60. Vaxxinova® Business Overview Table 61. Vaxxinova® Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Vaxxinova® Poultry Vaccines Product Portfolio Table 63. Vaxxinova® Recent Development Table 64. Elanco Company Information Table 65. Elanco Business Overview Table 66. Elanco Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Elanco Poultry Vaccines Product Portfolio Table 68. Elanco Recent Development Table 69. QYH Biotech Co., Ltd Company Information Table 70. QYH Biotech Co., Ltd Business Overview Table 71. QYH Biotech Co., Ltd Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. QYH Biotech Co., Ltd Poultry Vaccines Product Portfolio Table 73. QYH Biotech Co., Ltd Recent Development Table 74. Pulike Company Information Table 75. Pulike Business Overview Table 76. Pulike Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Pulike Poultry Vaccines Product Portfolio Table 78. Pulike Recent Development Table 79. Phibro Animal Health Corporation Company Information Table 80. Phibro Animal Health Corporation Business Overview Table 81. Phibro Animal Health Corporation Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Phibro Animal Health Corporation Poultry Vaccines Product Portfolio Table 83. Phibro Animal Health Corporation Recent Development Table 84. JinYu Biotechnology Company Information Table 85. JinYu Biotechnology Business Overview Table 86. JinYu Biotechnology Poultry Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. JinYu Biotechnology Poultry Vaccines Product Portfolio Table 88. JinYu Biotechnology Recent Development Table 89. Harbin Pharmaceutical Group Company Information Table 90. Harbin Pharmaceutical Group Business Overview Table 91. Harbin Pharmaceutical Group Poultry Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Harbin Pharmaceutical Group Poultry Vaccines Product Portfolio Table 93. Harbin Pharmaceutical Group Recent Development Table 94. MEVAC Company Information Table 95. MEVAC Business Overview Table 96. MEVAC Poultry Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. MEVAC Poultry Vaccines Product Portfolio Table 98. MEVAC Recent Development Table 99. Venky's Company Information Table 100. Venky's Business Overview Table 101. Venky's Poultry Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Venky's Poultry Vaccines Product Portfolio Table 103. Venky's Recent Development Table 104. Japfa Comfeed Indonesia Company Information Table 105. Japfa Comfeed Indonesia Business Overview Table 106. Japfa Comfeed Indonesia Poultry Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Japfa Comfeed Indonesia Poultry Vaccines Product Portfolio Table 108. Japfa Comfeed Indonesia Recent Development Table 109. Nisseiken Company Information Table 110. Nisseiken Business Overview Table 111. Nisseiken Poultry Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Nisseiken Poultry Vaccines Product Portfolio Table 113. Nisseiken Recent Development Table 114. Hile Company Information Table 115. Hile Business Overview Table 116. Hile Poultry Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Hile Poultry Vaccines Product Portfolio Table 118. Hile Recent Development Table 119. Hester Biosciences Company Information Table 120. Hester Biosciences Business Overview Table 121. Hester Biosciences Poultry Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hester Biosciences Poultry Vaccines Product Portfolio Table 123. Hester Biosciences Recent Development Table 124. North America Poultry Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Poultry Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Poultry Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Poultry Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Poultry Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Poultry Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Poultry Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Poultry Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Poultry Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Poultry Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Poultry Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Poultry Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 138. China Poultry Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 139. China Poultry Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 140. China Poultry Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 141. China Poultry Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Poultry Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Poultry Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Poultry Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Poultry Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Poultry Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Poultry Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Poultry Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Poultry Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Poultry Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Poultry Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Poultry Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Poultry Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Poultry Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Poultry Vaccines Image Figure 2. Global Poultry Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poultry Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Image Figure 5. Attenuated Image Figure 6. Killed Image Figure 7. Global Poultry Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Poultry Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 9. NDV Image Figure 10. Marek ' s Disease Image Figure 11. IBD Image Figure 12. Infectious Bronchitis Image Figure 13. Influenza Image Figure 14. Others Image Figure 15. Global Poultry Vaccines Market Size (US$ Million) & (2021-2032) Figure 16. Global Poultry Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Poultry Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Poultry Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Poultry Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Poultry Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Poultry Vaccines Revenue Market Share by Type (2021-2032) Figure 23. Global Poultry Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Poultry Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Poultry Vaccines Revenue Market Share by Application (2021-2032) Figure 26. North America Poultry Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Poultry Vaccines Revenue Share by Type (2021-2032) Figure 28. North America Poultry Vaccines Revenue Share by Application (2021-2032) Figure 29. North America Poultry Vaccines Revenue Share by Country (2021-2032) Figure 30. United States Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Poultry Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Poultry Vaccines Revenue Share by Type (2021-2032) Figure 35. Europe Poultry Vaccines Revenue Share by Application (2021-2032) Figure 36. Europe Poultry Vaccines Revenue Share by Country (2021-2032) Figure 37. Germany Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Poultry Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Poultry Vaccines Revenue Share by Type (2021-2032) Figure 47. China Poultry Vaccines Revenue Share by Application (2021-2032) Figure 48. Asia Poultry Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Poultry Vaccines Revenue Share by Type (2021-2032) Figure 50. Asia Poultry Vaccines Revenue Share by Application (2021-2032) Figure 51. Asia Poultry Vaccines Revenue Share by Region (2021-2032) Figure 52. Japan Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Poultry Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Poultry Vaccines Revenue Share by Type (2021-2032) Figure 60. SAMEA Poultry Vaccines Revenue Share by Application (2021-2032) Figure 61. SAMEA Poultry Vaccines Revenue Share by Country (2021-2032) Figure 62. Brazil Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Poultry Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Live
  • Attenuated
  • Killed
Applications
  • NDV
  • Marek ' s Disease
  • IBD
  • Infectious Bronchitis
  • Influenza
  • Others
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Ceva
  • Zoetis
  • Vaxxinova®
  • Elanco
  • QYH Biotech Co., Ltd
  • Pulike
  • Phibro Animal Health Corporation
  • JinYu Biotechnology
  • Harbin Pharmaceutical Group
  • MEVAC
  • Venky's
  • Japfa Comfeed Indonesia
  • Nisseiken
  • Hile
  • Hester Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Poultry Vaccines Market by Type
  3. 1.2.1 Global Poultry Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live
  5. 1.2.3 Attenuated
  6. 1.2.4 Killed
  7. 1.3 Poultry Vaccines Market by Application
  8. 1.3.1 Global Poultry Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 NDV
  10. 1.3.3 Marek ' s Disease
  11. 1.3.4 IBD
  12. 1.3.5 Infectious Bronchitis
  13. 1.3.6 Influenza
  14. 1.3.7 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Poultry Vaccines Market Dynamics
  1. 2.1 Poultry Vaccines Industry Trends
  2. 2.2 Poultry Vaccines Industry Drivers
  3. 2.3 Poultry Vaccines Industry Opportunities and Challenges
  4. 2.4 Poultry Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Poultry Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Poultry Vaccines Growth Trends by Region
  3. 3.2.1 Global Poultry Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Poultry Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Poultry Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Poultry Vaccines Revenue by Players
  2. 4.1.1 Global Poultry Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Poultry Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Poultry Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Poultry Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Poultry Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Poultry Vaccines Players, Product Type & Application
  8. 4.5 Global Poultry Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Poultry Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Poultry Vaccines Tier 1, Tier 2, and Tier 3
5 Poultry Vaccines Market Size by Type
  1. 5.1 Global Poultry Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Poultry Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Poultry Vaccines Revenue Market Share by Type (2021-2032)
6 Poultry Vaccines Market Size by Application
  1. 6.1 Global Poultry Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Poultry Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Poultry Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Poultry Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Poultry Vaccines Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim Poultry Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Poultry Vaccines Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 Ceva
  14. 7.3.1 Ceva Company Information
  15. 7.3.2 Ceva Business Overview
  16. 7.3.3 Ceva Poultry Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Ceva Poultry Vaccines Product Portfolio
  18. 7.3.5 Ceva Recent Developments
  19. 7.4 Zoetis
  20. 7.4.1 Zoetis Company Information
  21. 7.4.2 Zoetis Business Overview
  22. 7.4.3 Zoetis Poultry Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Zoetis Poultry Vaccines Product Portfolio
  24. 7.4.5 Zoetis Recent Developments
  25. 7.5 Vaxxinova®
  26. 7.5.1 Vaxxinova® Company Information
  27. 7.5.2 Vaxxinova® Business Overview
  28. 7.5.3 Vaxxinova® Poultry Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Vaxxinova® Poultry Vaccines Product Portfolio
  30. 7.5.5 Vaxxinova® Recent Developments
  31. 7.6 Elanco
  32. 7.6.1 Elanco Company Information
  33. 7.6.2 Elanco Business Overview
  34. 7.6.3 Elanco Poultry Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Elanco Poultry Vaccines Product Portfolio
  36. 7.6.5 Elanco Recent Developments
  37. 7.7 QYH Biotech Co., Ltd
  38. 7.7.1 QYH Biotech Co., Ltd Company Information
  39. 7.7.2 QYH Biotech Co., Ltd Business Overview
  40. 7.7.3 QYH Biotech Co., Ltd Poultry Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 QYH Biotech Co., Ltd Poultry Vaccines Product Portfolio
  42. 7.7.5 QYH Biotech Co., Ltd Recent Developments
  43. 7.8 Pulike
  44. 7.8.1 Pulike Company Information
  45. 7.8.2 Pulike Business Overview
  46. 7.8.3 Pulike Poultry Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pulike Poultry Vaccines Product Portfolio
  48. 7.8.5 Pulike Recent Developments
  49. 7.9 Phibro Animal Health Corporation
  50. 7.9.1 Phibro Animal Health Corporation Company Information
  51. 7.9.2 Phibro Animal Health Corporation Business Overview
  52. 7.9.3 Phibro Animal Health Corporation Poultry Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Phibro Animal Health Corporation Poultry Vaccines Product Portfolio
  54. 7.9.5 Phibro Animal Health Corporation Recent Developments
  55. 7.10 JinYu Biotechnology
  56. 7.10.1 JinYu Biotechnology Company Information
  57. 7.10.2 JinYu Biotechnology Business Overview
  58. 7.10.3 JinYu Biotechnology Poultry Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 JinYu Biotechnology Poultry Vaccines Product Portfolio
  60. 7.10.5 JinYu Biotechnology Recent Developments
  61. 7.11 Harbin Pharmaceutical Group
  62. 7.11.1 Harbin Pharmaceutical Group Company Information
  63. 7.11.2 Harbin Pharmaceutical Group Business Overview
  64. 7.11.3 Harbin Pharmaceutical Group Poultry Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Harbin Pharmaceutical Group Poultry Vaccines Product Portfolio
  66. 7.11.5 Harbin Pharmaceutical Group Recent Developments
  67. 7.12 MEVAC
  68. 7.12.1 MEVAC Company Information
  69. 7.12.2 MEVAC Business Overview
  70. 7.12.3 MEVAC Poultry Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 MEVAC Poultry Vaccines Product Portfolio
  72. 7.12.5 MEVAC Recent Developments
  73. 7.13 Venky's
  74. 7.13.1 Venky's Company Information
  75. 7.13.2 Venky's Business Overview
  76. 7.13.3 Venky's Poultry Vaccines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Venky's Poultry Vaccines Product Portfolio
  78. 7.13.5 Venky's Recent Developments
  79. 7.14 Japfa Comfeed Indonesia
  80. 7.14.1 Japfa Comfeed Indonesia Company Information
  81. 7.14.2 Japfa Comfeed Indonesia Business Overview
  82. 7.14.3 Japfa Comfeed Indonesia Poultry Vaccines Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Japfa Comfeed Indonesia Poultry Vaccines Product Portfolio
  84. 7.14.5 Japfa Comfeed Indonesia Recent Developments
  85. 7.15 Nisseiken
  86. 7.15.1 Nisseiken Company Information
  87. 7.15.2 Nisseiken Business Overview
  88. 7.15.3 Nisseiken Poultry Vaccines Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Nisseiken Poultry Vaccines Product Portfolio
  90. 7.15.5 Nisseiken Recent Developments
  91. 7.16 Hile
  92. 7.16.1 Hile Company Information
  93. 7.16.2 Hile Business Overview
  94. 7.16.3 Hile Poultry Vaccines Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Hile Poultry Vaccines Product Portfolio
  96. 7.16.5 Hile Recent Developments
  97. 7.17 Hester Biosciences
  98. 7.17.1 Hester Biosciences Company Information
  99. 7.17.2 Hester Biosciences Business Overview
  100. 7.17.3 Hester Biosciences Poultry Vaccines Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Hester Biosciences Poultry Vaccines Product Portfolio
  102. 7.17.5 Hester Biosciences Recent Developments
8 North America
  1. 8.1 North America Poultry Vaccines Revenue (2021-2032)
  2. 8.2 North America Poultry Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Poultry Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Poultry Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Poultry Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Poultry Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Poultry Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Poultry Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Poultry Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Poultry Vaccines Revenue by Country
  11. 8.6.1 North America Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Poultry Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Poultry Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Poultry Vaccines Revenue (2021-2032)
  2. 9.2 Europe Poultry Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Poultry Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Poultry Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Poultry Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Poultry Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Poultry Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Poultry Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Poultry Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Poultry Vaccines Revenue by Country
  11. 9.6.1 Europe Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Poultry Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Poultry Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Poultry Vaccines Revenue (2021-2032)
  2. 10.2 China Poultry Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Poultry Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Poultry Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Poultry Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Poultry Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Poultry Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Poultry Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Poultry Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Poultry Vaccines Revenue (2021-2032)
  2. 11.2 Asia Poultry Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Poultry Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Poultry Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Poultry Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Poultry Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Poultry Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Poultry Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Poultry Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Poultry Vaccines Revenue by Country
  11. 11.6.1 Asia Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Poultry Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Poultry Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Poultry Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Poultry Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Poultry Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Poultry Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Poultry Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Poultry Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Poultry Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Poultry Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Poultry Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Poultry Vaccines Revenue by Country
  11. 12.6.1 SAMEA Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Poultry Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Poultry Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research